Etonogestrel-Ethinyl Estradiol
Medically Reviewed by Dr. Harshi Dhingra, M.D.
Last Reviewed: Jul 23, 2024
Warnings
Etonogestrel - Ethinyl Estradiol (NuvaRing) Risks, Warnings, and Complications
Ethinyl estradiol - etonogestrel can cause serious adverse effects in certain high-risk people. Talk to your doctor about alternative methods of birth control if you are at a high risk of complications from combination hormonal birth control. Some of the potential risks of etonogestrel - ethinyl estradiol are listed below. Note: There are several health risks associated with the use of third generation oral contraceptives (including etonogestrel and ethinyl estradiol which are present in NuvaRing). These risks include thromboembolism (blood clots), heart attack, and stroke. There is no data to suggest that the risks associated with ethinyl estradiol concentrations observed with the vaginal route of administration (contraceptive ring) are any different from serum ethinyl estradiol concentrations achieved with oral contraceptives taken by mouth.
|
Precautions Before Starting Etonogestrel - Ethinyl Estradiol (NuvaRing)
Tell your doctor if you have had allergic reactions to etonogestrel, ethinyl estradiol, any of the active or inactive ingredients in the vaginal ring, other hormonal contraceptives, or any other drugs. Your pharmacy can give you a list of ingredients.
Give your doctor or pharmacist a complete list of your medications, including prescription drugs, over-the-counter medicines, vitamins, supplements, and herbal products, especially St. John’s Wort. This can help avoid possible drug interactions between etonogestrel - ethinyl estradiol and your other medications.
Give your doctor a complete medical history. Etonogestrel - ethinyl estradiol may not be safe for people with certain medical conditions, such as blood clots, cerebrovascular disease, stroke, chest pain, coronary artery disease, heart attack, heart rhythm abnormalities, heart valve problems, high cholesterol, diabetes, high blood pressure, kidney problems, problems with blood vessels, nerves, or eyes, circulation problems, headaches, vision changes, liver disease, liver tumors, jaundice, bleeding disorders, abnormal vaginal bleeding, breast problems (fibrocystic breast disease, breast nodules, abnormal mammogram), personal or family history of breast cancer, other types of cancers, hereditary angioedema, seizures, depression, dark patches on the skin (melasma), prolapsed (dropped) bladder, rectum, or uterus, conditions that make your vagina more prone to irritation, toxic shock syndrome, thyroid disease, or gallbladder disease. Also tell your doctor if you have recently delivered a baby or suffered a miscarriage or abortion.
Tell your doctor if you are pregnant or could be pregnant. You should not use etonogestrel - ethinyl estradiol vaginal ring if you are pregnant. Also, you should not use the vaginal ring if you are nursing an infant with breast milk as it can affect breast milk production.
Precautions During Use of Etonogestrel - Ethinyl Estradiol (NuvaRing)
Keep all your medical and lab appointments while on etonogestrel - ethinyl estradiol. Your doctor may want to perform a physical examination and/or order certain laboratory tests.
In case of a missed menstrual period, if you have not followed the prescribed method of using the vaginal ring (i.e., you left the vaginal ring out for more than 3 hours or had a ring-free interval of more than one week), you should do a pregnancy test after the first missed menstrual period. Discontinue use of the vaginal ring if a pregnancy is confirmed. If you used the vaginal ring as prescribed, do a pregnancy test after two consecutive missed periods. If you retain the vaginal ring for one extra week (a total of four weeks), remove it, allow a ring-free one-week period, and insert a new ring. If you retained the vaginal ring for more than 4 weeks, do a pregnancy test to rule out pregnancy before inserting a new ring.
Tell your health care professionals you are using a contraceptive ring before any surgery, including dental procedures. You may need to temporarily stop using the ring to lower your risk of blood clots before and after certain surgical procedures.
If you note any vision changes or difficulty in wearing contact lenses, see your eye doctor.
Hormonal contraceptive use can lead to dark patches (hyperpigmentation) of the facial skin. Before starting treatment, tell your doctor if you’ve had skin discoloration (melasma) from hormonal contraceptives or during pregnancy in the past. Wear protective clothing and use sunscreen to protect your skin from sunlight.
Talk to your doctor if you develop symptoms of severe depression or mood changes while using etonogestrel - ethinyl estradiol.
Etonogestrel - Ethinyl Estradiol (NuvaRing) Drug Interactions
The use of hormonal contraceptives with certain other medicines can affect how the medications work. Using certain combinations of drugs together can increase the risk of severe adverse effects. Your doctor may change the doses of your medications, switch you to different medications, and/or monitor you carefully for adverse effects if there are known interactions between etonogestrel - ethinyl estradiol and your other medicines.
You should not take the following medications with etonogestrel - ethinyl estradiol:
- Combination of ombitasvir, paritaprevir, and ritonavir (Technivie) with or without dasabuvir (in Viekira Pak)
The following medications can also have interactions with etonogestrel - ethinyl estradiol:
- Acetaminophen (Tylenol, others)
- Medications used to treat fungal infections, such as itraconazole (Onmel, Sporanox), ketoconazole (Nizoral), fluconazole (Diflucan), griseofulvin (Gris-Peg), miconazole (Oravig), and voriconazole (Vfend)
- Medications prescribed for nausea and vomiting, such as aprepitant (Emend)
- Vitamin C (ascorbic acid)
- Cholesterol-lowering drugs such as atorvastatin (Lipitor) and clofibric acid
- Medications prescribed for seizure disorders, such as barbiturates, carbamazepine (Tegretol, Teril, others), topiramate (Topamax), lamotrigine (Lamictal), oxcarbazepine (Trileptal), felbamate (Felbatol), phenobarbital, and phenytoin (Dilantin, Phenytek)
- Medications for pulmonary arterial hypertension, such as bosentan (Tracleer)
- Immunosuppressants such as cyclosporine (Neoral, Sandimmune, Gengraf)
- HIV/AIDS medications such as darunavir (Prezista) with ritonavir (Norvir), atazanavir (Reyataz), delavirdine (Rescriptor), etravirine (Intelence), efavirenz (Sustiva), indinavir (Crixivan), nelfinavir (Viracept), lopinavir (Kaletra), nevirapine (Viramune), saquinavir (Invirase), tipranavir (Aptivus), and ritonavir (Norvir)
- Pain medications such as morphine (Kadian, Astramorph, others)
- Corticosteroids such as prednisolone (Orapred)
- Antibiotic treatment for tuberculosis, such as rifabutin (Mycobutin), rifampin (Rifadin, Rimactane), rufinamide (Banzel)
- Insomnia medications such as temazepam (Restoril)
- Medications used to treat lung conditions, such as theophylline (Elixophyllin, Theo-24, others)
- Muscle relaxants such as tizanidine (Zanaflex)
- Thyroid hormone
The above list may not include all the possible interactions of etonogestrel - ethinyl estradiol. Give your doctor or pharmacist a complete list of your medications, including prescription drugs, over-the-counter medicines, dietary supplements, and herbal remedies. Also, tell your healthcare provider if you smoke, drink alcohol, or use recreational drugs because some of these substances can cause serious health complications when used with prescription and over-the-counter medicines.
SOCIAL